TickerFacts.

Nika Pharmaceuticals, Inc (NIKA): Shareholders' Equity

Annual figures by period end, from SEC filings.

-$297.6K
As of 2025-12-31
-$330.7K
As of 2026-06-30
2020-12-31: -$8.9K2021-12-31: -$23.6K2022-12-31: -$17.3K2023-12-31: -$82.1K2024-12-31: -$221.2K2025-12-31: -$297.6K-$297.6K
2020-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31-$297.6Kn/m2026-03-25, Balance as of period end
2024-12-31-$221.2Kn/m2026-03-25, Balance as of period end
2023-12-31-$82.1Kn/m2025-03-31, Balance as of period end
2022-12-31-$17.3Kn/m2024-04-01, Balance as of period end
2021-12-31-$23.6Kn/m2023-04-10, Balance as of period end
2020-12-31-$8.9Kn/a2022-03-03, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Nika Pharmaceuticals, Inc (NIKA)2025-12-31-$297.6Kn/m
CNBX Pharmaceuticals Inc. (CNBX)2025-08-31-$2.50Mn/m
One World Products, Inc. (OWPC)2024-12-31-$9.91Mn/m
Skinvisible, Inc. (SKVI)2025-12-31-$10.26Mn/m
Bioadaptives, Inc. (BDPT)2025-12-31-$2.13Mn/m
Regen BioPharma Inc (RGBP)2025-09-30-$6.28Mn/m
Cell Source, Inc. (CLCS)2024-12-31-$18.54Mn/m
ZyVersa Therapeutics, Inc. (ZVSA)2025-12-31-$12.39Mn/m
Bespoke Extracts, Inc. (BSPK)2024-12-31-$2.09Mn/m

Compare NIKA, CNBX, OWPC, SKVI side by side · Screen every company in Pharmaceutical Preparations ↗